Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. (Q33661457)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

title

Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

main subject

aflibercept

1 reference

based on heuristic

inferred from title

author

Ludovico Iannetti

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

Francesco Parisi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

Umberto De Vico

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

Marco Marenco

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

author name string

Magda Gharbiya

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

Maria Laura Mungo

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

language of work or name

English

0 references

publication date

7 May 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

published in

BioMed Research International

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

volume

2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

page(s)

273754

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

copyright license

Creative Commons Attribution 3.0 Unported

start time

1 January 2014

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

stated in

April 2022 Public Data File from Crossref

cites work

Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

21 June 2018

Predicted biological activity of intravitreal VEGF Trap

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1155%2F2014%2F273754

retrieved

21 January 2018

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1155%2F2014%2F273754

retrieved

21 January 2018

Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1155%2F2014%2F273754

retrieved

21 January 2018

Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033502

retrieved

30 October 2018

Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24895562

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24895562

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24895562

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24895562

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1155/2014/273754

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

PMC publication ID

4033502

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

PubMed publication ID

24895562

1 reference

stated in

Europe PubMed Central

PMC publication ID

4033502

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24895562%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 March 2020

ResearchGate publication ID

262844253

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33661457&oldid=1981700604"